Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modulation of human dUTPase using small interfering RNA.

A W Studebaker1, W P Lafuse, R Kloesel

  • 1Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.

Biochemical and Biophysical Research Communications
|January 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highly Conformal Craniospinal Radiotherapy Techniques Can Underdose the Cranial Clinical Target Volume if Leptomeningeal Extension through Skull Base Exit Foramina is not Contoured.

Clinical oncology (Royal College of Radiologists (Great Britain))·2017
Same author

Reply to Comment on: The UK Experience of a Treatment Strategy for Pediatric Metastatic Medulloblastoma Comprising Intensive Induction Chemotherapy, Hyperfractionated Accelerated Radiotherapy, and Response-Directed High-Dose Myeloablative Chemotherapy or Maintenance Chemotherapy (Milan Strategy).

Pediatric blood & cancer·2016
Same author

Quantifying uncertainty in radiotherapy demand at the local and national level using the Malthus model.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014
Same author

The Malthus Programme: developing radiotherapy demand models for breast and prostate cancer at the local, regional and national level.

Clinical oncology (Royal College of Radiologists (Great Britain))·2013
Same author

Radiotherapy demand and activity in England 2006-2020.

Clinical oncology (Royal College of Radiologists (Great Britain))·2013
Same author

Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors.

British journal of cancer·2013
Same journal

The plasma membrane H<sup>+</sup>-ATPase OSA2 negatively regulates salt tolerance in rice seedlings.

Biochemical and biophysical research communications·2026
Same journal

MiR-425-5p modulation of CREB1 affects inflammatory response and motor recovery after spinal cord injury.

Biochemical and biophysical research communications·2026
Same journal

Xanthoangelol, a chalcone from Angelica keiskei, induces apoptosis in cervical cancer cell lines via the oxidative stress-mediated activation of caspase-8 and caspase-9.

Biochemical and biophysical research communications·2026
Same journal

Suchilactone ameliorates podocyte injury in membranous nephropathy by modulating the JNK/p38 MAPK pathway in vitro.

Biochemical and biophysical research communications·2026
Same journal

Palmitic acid-induced metabolic stress alters differentiation-associated gene expression in human ameloblast-like cells.

Biochemical and biophysical research communications·2026
Same journal

A transferrin receptor-based vector enables robust Type-II membrane protein display on mammalian cells.

Biochemical and biophysical research communications·2026
See all related articles

Short-interfering RNA (siRNA) effectively reduced deoxyuridine triphosphate nucleotidohydrolase (dUTPase) activity, increasing intracellular dUTP levels and decreasing cell proliferation. This highlights dUTPase as a potential drug target for DNA metabolism modulation.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Deoxyuridine triphosphate nucleotidohydrolase (dUTPase) maintains low intracellular dUTP levels, preventing its incorporation into DNA.
  • Aberrant dUTP levels can impact DNA integrity and cellular function.

Purpose of the Study:

  • To investigate the efficacy of RNA interference (RNAi) in down-regulating dUTPase expression and activity.
  • To assess the impact of dUTPase down-regulation on intracellular dUTP levels and cell proliferation.
  • To evaluate dUTPase as a potential therapeutic target.

Main Methods:

  • Transfection of human cell lines with a specific 21 bp double-stranded RNA molecule (siRNAdUT3) targeting human dUTPase mRNA.
  • Measurement of dUTPase activity over time and in a dose-dependent manner.

Related Experiment Videos

  • Quantification of intracellular dUTP levels.
  • Assessment of cell proliferation rates post-transfection.

    • Main Results:

    • siRNAdUT3 treatment resulted in a time- and dose-dependent decrease in dUTPase activity, reaching approximately 95% reduction at 48 hours.
    • Reduced dUTPase activity was sustained for at least 72 hours post-transfection.
    • Down-regulation of dUTPase led to a significant increase in intracellular dUTP levels.
    • Transfected cells exhibited decreased proliferation rates.

    Conclusions:

    • RNA interference using siRNA is an effective method for specifically down-regulating dUTPase expression and activity.
    • dUTPase plays a critical role in maintaining genomic stability by controlling intracellular dUTP levels.
    • Targeting dUTPase via siRNA presents a promising strategy for further research into DNA metabolism and potential drug development.